Title : The Gut-Brain Axis in Neurodegenerative Diseases
Abstract:
Amyloid plaques in Alzheimer’s disease (AD) are associated with inflammation. Recent studies have demonstrated the involvement of gut in central amyloid-beta (Aβ) pathogenesis; still the mechanisms are not well understood. Dysregulation in gut pathophysiology due to imbalanced microbiota may be involved in promoting chronic inflammation. Using Tg2576 AD mice we tested the hypothesis that gut bears the Aβ burden prior to brain. We used presymptomatic 6-months old and symptomatic 15-months old Tg2576 compared to their age-matched littermate WT control mice. We study human AD patients gastrointestinal microbiome profiling. We identified that dysfunction of intestinal epithelial barrier (IEB), dysregulation of absorption, and vascular Aβ deposition in the IEB occur before central Aβ aggregation is detectible. The intestinal dysfunction observed before brain pathology was associated with elevated inflammatory and angiogenic plasma cytokines like IL-9, VEGF, and IP-10. When we measure human oral microbiota profiling we see a distinct separation of bacterial composition from AD patients compared to control subjects. Our novel data provide evidence that gut dysfunction in association with dysbiotic gut microbiota occurs in AD and may contribute to its etiology.
What will audience learn from your presentation?
- Audience will learn that neurology diseases does not always originate from brain. Peripheral components plays a major role in central disease progression
- Audience will understand the importance of a healthy microbiome and how much they can impact the health of an individual with age.